The FDA Says They Have Received Reports Of Various Cancers Occurring In The Scar Tissue Around Breast Implants
The U.S. Food and Drug Administration (FDA) has received reports of cancer occurring in the scar tissue that forms around breast implants, according to the agency’s latest statement.
Less than thirty cases of lymphomas and less than twenty cases of SCC occurring in the scar tissue capsule have been reported to the FDA.
However, about four hundred thousand women seek out breast implants each year– about seventy-five percent for cosmetic reasons and the remaining twenty-five percent for reconstruction.
In turn, the FDA is urging both the public and medical professionals to be cognizant of the risk.
“While the FDA believes that occurrences of SCC and various lymphomas in the capsule around the breast implant may be rare, health care providers and people who have or are considering breast implants should be aware that cases have been reported to the FDA and in the literature,” the statement underscores.
The FDA also provided recommendations for people who have breast implants, people who are considering the medical procedure, and health care providers.
If you currently have breast implants, the agency said that you do not need to alter your medical care routine. Instead, monitor your implants and, if you notice anything out of the ordinary, visit your surgeon for a consultation.
On the other hand, if you are considering receiving breast implants, the FDA urges you to review their case study and resources to become educated on the risks and benefits.
Finally, health care providers are encouraged to continue providing routine care while recognizing that cases of lymphomas and SCC have been reported.
New Africa – illustrative purpose only, not the actual person
Sign up for Chip Chick’s newsletter and get stories like this delivered to your inbox.
“When examining breast implant specimens (for example, seroma, capsule, devices) for diagnostic evaluation, characterize all findings and potential diagnoses,” the FDA said.
Additionally, any findings of lymphomas, SCC, or other cancers surrounding the breast implant should be immediately reported to the FDA.
In the meantime, the agency has detailed its commitment to ensuring public safety.
“The FDA is continually evaluating the postmarket safety of approved breast implants and communicating about the risks associated with these devices. We will continue to communicate to the public on significant findings as new information and analyses become available.”
To read the FDA’s complete statement, visit the link here.
If true crime defines your free time, this is for you: join Chip Chick’s True Crime Tribe
The Terrifying True Tale Of The Real Annabelle Doll And What Her Reign Of Terror Looked Like
More About:Science
Read This Next
